These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 28081768)

  • 21. Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.
    Samycia M; Brassard A
    J Cutan Med Surg; 2013 Oct; 17 Suppl 1():S23-32. PubMed ID: 24144253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidradenitis suppurativa: a review with a focus on treatment data.
    Barlev D; Eisen DB; Alikhan A
    Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
    Alhusayen R; Shear NH
    Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Update on Medical Treatment Options for Hidradenitis Suppurativa.
    Deckers IE; Prens EP
    Drugs; 2016 Feb; 76(2):215-29. PubMed ID: 26659474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 28. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa.
    Tzanetakou V; Stergianou D; Giamarellos-Bourboulis EJ
    Expert Opin Drug Saf; 2020 Apr; 19(4):381-393. PubMed ID: 32098513
    [No Abstract]   [Full Text] [Related]  

  • 31. Hidradenitis suppurativa: Current and emerging treatments.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
    Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
    Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
    Yen CF; Huang YH; Chi CC
    Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
    Shuja F; Chan CS; Rosen T
    Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is hidradenitis suppurativa?
    Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J
    Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
    Theut Riis P; Thorlacius LR; Jemec GB
    Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic approach to Crohn disease: possible parallels with hidradenitis suppurativa.
    González Lama Y; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():2-7. PubMed ID: 28081765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
    Kimball AB; Okun MM; Williams DA; Gottlieb AB; Papp KA; Zouboulis CC; Armstrong AW; Kerdel F; Gold MH; Forman SB; Korman NJ; Giamarellos-Bourboulis EJ; Crowley JJ; Lynde C; Reguiai Z; Prens EP; Alwawi E; Mostafa NM; Pinsky B; Sundaram M; Gu Y; Carlson DM; Jemec GB
    N Engl J Med; 2016 Aug; 375(5):422-34. PubMed ID: 27518661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidradenitis suppurativa managed with adalimumab.
    Yamauchi PS; Mau N
    J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
    Giuffrida R; Cannavò SP; Coppola M; Guarneri C
    Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.